−2700KRW
−30.73 BKRW
124.64 BKRW
6.86 M
About KLS
Sector
CEO
Woo-Seok Lee
Headquarters
Seoul
Website
Employees (FY)
440
Founded
2000
ISIN
KR7102940004
FIGI
BBG000CFXQJ8
KOLON Life Science, Inc. engages in the manufacture and sale of pharmaceuticals and environment materials. It operates through the Pharmaceuticals and Environment Businesses. The Pharmaceutical business provides cell and gene therapeutics. The Environment business offers antibacterial and water treatment agents. The company was founded on April 21, 2000 and is headquartered in Seoul, South Korea.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 102940 is 22200.00 KRW — it has increased by 1.37% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange KLS stocks are traded under the ticker 102940.
KLS is going to release the next earnings report on May 13, 2024. Keep track of upcoming events with our Earnings Calendar.
Yes, you can track KLS financials in yearly and quarterly reports right on TradingView.
102940 stock has fallen by 0.89% compared to the previous week, the month change is a 4.31% fall, over the last year KLS has showed a 36.57% decrease.
Like other stocks, 102940 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade KLS stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 440.00 employees. See our rating of the largest employees — is KLS on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. KLS EBITDA is −15.10 B KRW, and current EBITDA margin is −12.34%. See more stats in KLS financial statements.